The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
Abstract
BACKGROUND: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. OBJECTIVE: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. DESIGN: Population-based, retrospective cohort study. SETTING: Ontario, Canada. PATIENTS: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. MEASUREMENTS: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. RESULTS: A total of 27,259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that increase the risk for death could diminish or eliminate the observed associations. LIMITATIONS: Information on causes of death was not available. Many patients did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. CONCLUSIONS: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A similar black box warning for conventional antipsychotics, based on two observational studies that showed increased risk of mortality in older adults using conventional versus atypical antipsychotics, was announced in 2008.117 118 119”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, it announced a black box warning for the use of atypical antipsychotics for behavioral and psychological symptoms of dementia.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2005, the FDA announced that, based on a re-analysis of 17 placebo controlled trials (several of which were unpublished), atypical antipsychotics were associated with a 1.7-fold increase in mortality compared with placebo.117 118”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A meta-analysis found an odds ratio for mortality with these drugs of 1.54 (1.06 to 2.23; Z=2.28; P=0.02), with pooled events of 3.5% mortality for the drug versus 2.3% for placebo.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have shown that nonpharmacological treatments pose fewer side effects, which render them as safer options [20].”
From Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review (2015) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Rosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 6,472
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206
Austin, P. C., Grootendorst, P. V., & Anderson, G. M. (2006) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,138
Self-citationRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Effectiveness of Collaborative Care for Older Adults With Alzheimer Disease in Primary Care
Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., Fultz, B. A., Hui, S. L., Counsell, S. R., & Hendrie, H. C. (2006) · JAMA · doi:10.1001/jama.295.18.2148 · Cited by 799
Research works printed but not linked: 4
- Levy AR, 2003, Can J Clin Pharmacol, 10, 67
- 10.1080/00031305.1985.10479383 · DOI
- Trifirò G, 2006, Pharmacoepidemiol Drug Saf
- Gill SS, 2006, JAMA, 295, 495
Cited by
Sorted by citations
Items 301–400 of 618
Associated mortality risk of atypical antipsychotic medication in individuals with dementia
Phiri, P., Engelthaler, T., Carr, H., Delanerolle, G., Holmes, C., & Rathod, S. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i2.298 · Cited by 15
Selbæk, G., Aarsland, D., Ballard, C. G., Engedal, K., Langballe, E. M., Benth, J. Š., & Bergh, S. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.01.016 · Cited by 15
Šubic, A., Županič, E., von Euler, M., Norrving, B. G., Čermáková, P., Religa, D., Winblad, B. G., Kramberger, M. G., Eriksdotter, M., & Ptacek, S. G. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666181002134155 · Cited by 15
Donovan, J. L., Kanaan, A. O., Thomson, M. S., Rochon, P. A., Lee, M. M., Gavendo, L., Zhao, Y., Baril, J. L., Field, T. S., & Gurwitz, J. H. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02840.x · Cited by 16
Self-citationStephenson, A. L., Seitz, D. P., Fischer, H. D., Gruneir, A., Bell, C. M., Gershon, A. S., Fu, L., Anderson, G., Austin, P. C., Rochon, P. A., et al. (2012) · Drugs & Aging · doi:10.2165/11599480-000000000-00000 · Cited by 14
Self-citationLongitudinal Trends and Variation in Antipsychotic Use in Older Adults After Cardiac Surgery
Kim, D. H., Mahesri, M., Bateman, B. T., Huybrechts, K. F., Inouye, S. K., Marcantonio, E. R., Herzig, S. J., Ely, E. W., Pisani, M. A., Levin, R., et al. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15418 · Cited by 15
Non‐medical care for geriatric patients
Ishizuka, S., Azumi, M., Fujii, M., & Sasaki, H. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00718.x · Cited by 14
Watt, J. A., Goodarzi, Z., Tricco, A. C., Veroniki, A. A., & Straus, S. E. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0572-x · Cited by 15
Singer, A. G., Kosowan, L., Katz, A., Jolin‐Dahel, K., Appel, K., & Lix, L. M. (2018) · CMAJ Open · doi:10.9778/cmajo.20180053 · Cited by 14
Luijendijk, H. J., Bruin, N. C. D., Hulshof, T. A., & Koolman, X. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3912 · Cited by 14
Antipsychotic Drug Treatment in Ambulatory Dementia Care: Prevalence and Correlates
Eichler, T. S., Wucherer, D., Thyrian, J. R., Kilimann, I., Hertel, J., Michalowsky, B., Teipel, S. J., & Hoffmann, W. U. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141554 · Cited by 13
Strategies for the Prescription of Psychotropic Drugs with Black Box Warnings
Stevens, J. R., Jarrahzadeh, T., Brendel, R. W., & Stern, T. A. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.08.009 · Cited by 13
Long‐term outcomes of elders discharged on antipsychotics
Loh, K. P., Ramdass, S. K., Garb, J., Thim, M., Brennan, M. J., Lindenauer, P. K., & Lagu, T. C. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2585 · Cited by 13
Tjia, J., Reidenberg, M. M., Hunnicutt, J. N., Paice, K. M., Donovan, J. L., Kanaan, A. O., Briesacher, B. A., & Lapane, K. L. (2015) · The Consultant Pharmacist · doi:10.4140/tcp.n.2015.599 · Cited by 13
Statin discontinuation and new antipsychotic use after an acute hospital stay vary by hospital
Coe, A. B., Vincent, B. M., & Iwashyna, T. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232707 · Cited by 15
Gómez‐Pavón, J., García, P. G., Román, I. F., Astiz, M. V., Rodríguez, J. G., Díaz, G. J., Fernández, N. P. M., Fernández, B., & Páez, J. M. J. (2010) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2009.10.002 · Cited by 15
Behavioral and Psychological Symptoms of Dementia
Wu, S., & Yu, R. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_823-1 · Cited by 13
Gisev, N., Hartikainen, S. A., Chen, T. F., Korhonen, M., & Bell, J. S. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000117 · Cited by 13
Vasilyeva, I., Biscontri, R. G., Enns, M. W., Metge, C. J., & Alessi‐Severini, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064217 · Cited by 12
Delirium in Palliative Care Patients: Focus on Pharmacotherapy
Zimmerman, K. M., Rudolph, J. L., Salow, M., & Skarf, L. M. (2011) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909111403732 · Cited by 12
Lesén, E., Carlsten, A., Skoog, I. G., Wærn, M., Petzold, M., & Börjesson‐Hanson, A. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000524 · Cited by 12
Huybrechts, K. F., Gerhard, T., Franklin, J. M., Levin, R., Crystal, S., & Schneeweiß, S. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3611 · Cited by 12
Rikala, M., Hartikainen, S. A., Saastamoinen, L., & Korhonen, M. J. (2013) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1384 · Cited by 13
Shiltz, D. L., Lineweaver, T. T., Brimmer, T., Cairns, A. C., Halcomb, D. S., Juett, J., Beer, L. E., Hay, D. P., & Plewes, J. M. (2018) · GeroPsych · doi:10.1024/1662-9647/a000180 · Cited by 12
Daniels, L. M., Nelson, S. B., Frank, R. D., & Park, J. G. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.06.022 · Cited by 13
Sultana, J., Giorgianni, F., Rea, F., Lucenteforte, E., Lombardi, N., Mugelli, A., Vannacci, A., Liperoti, R., Kirchmayer, U., Vitale, C., et al. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1561860 · Cited by 12
Randle, J. M., Heckman, G. A., Oremus, M., & Ho, J. M.-W. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5106 · Cited by 12
Sikirica, S., Marino, M., Gagne, J. J., Palma, R. D., & Maio, V. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12099 · Cited by 12
Adverse Events Associated with Antipsychotic Use in Hospitalized Older Adults After Cardiac Surgery
Kim, D. H., Huybrechts, K. F., Patorno, E., Marcantonio, E. R., Park, Y., Levin, R., Abdurrob, A., & Bateman, B. T. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14768 · Cited by 12
Christiansen, C. F., Christensen, S., Riis, A. H., Thomsen, R. W., Johnsen, S. P., Tønnesen, E., & Sørensen, H. T. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03803.x · Cited by 12
The Pharmacoepidemiology of Psychiatric Medications
Wang, P. S., Brookhart, A. M., Ulbricht, C. M., & Schneeweiß, S. (2011) · Wiley eBooks · doi:10.1002/9780470976739.ch10 · Cited by 12
Wada, M., YASUDA, H., Nakajima, S., Etani, T., Miura, A., Asada, S., Yoshida, K., Noda, Y., & Takeuchi, H. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.08.011 · Cited by 12
Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes
Trang, D. T., Cool, C., de Mazières, C. L., Lapeyre‐Mestre, M., Montastruc, J., Rascol, O., Rolland, Y., & Sommet, A. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.04.014 · Cited by 12
Prevention of delirium with agitation by yokukansan in older adults after cancer surgery
Sadahiro, R., Wada, S., Matsuoka, Y., Uchitomi, Y., Yamaguchi, T., Sato, T., Esaki, M., Yoshimoto, S., Daiko, H., Kanemitsu, Y., et al. (2022) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyac123 · Cited by 11
The Impact of FDA's Warning on the Use of Antipsychotics in Clinical Practice: A Survey
Saad, M., Cassagnol, M., & Ahmed, E. (2010) · The Consultant Pharmacist · doi:10.4140/tcp.n.2010.739 · Cited by 11
Izquierdo, N. B., Bioque, M., & Bernardo, M. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000153 · Cited by 11
Chiu, Y., Huang, C.-W., Chen, P., Yu, N., Tsai, H., Wu, C., & Chang, C. (2017) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000181 · Cited by 11
Bell, K., Hartmann, C. W., & Baughman, A. W. (2020) · BMJ Open Quality · doi:10.1136/bmjoq-2020-000997 · Cited by 11
Kindstedt, J., Sjölander, M., Lövheim, H., & Gustafsson, M. V. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03241-7 · Cited by 12
Reducing antipsychotic prescriptions in primary care: a healthcare perspective
Mavrodaris, A., & Philp, I. (2013) · Journal of Public Mental Health · doi:10.1108/17465721311304258 · Cited by 11
Calvó‐Perxas, L., Garriga, O. T., Aguirregomozcorta, M., Bisbe, J., Hernández, E., Pousa, S. L., Manzano, A., Palacios, M., Nierga, I. P., Perkal, H., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.02.003 · Cited by 11
Therapeutic Advances in the Prevention and Treatment of Delirium in the Hospital Setting
Kluger, C. G., Shah, P. A., Maiti, S., Babalola, O., Mulvany, C., & Sinvani, L. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000673 · Cited by 11
Singer, A. G., Kosowan, L., Abrams, E. M., Katz, A., Lix, L. M., Leong, K., & Paige, A. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01912-7 · Cited by 10
Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization
Zhang, Y., Wilkins, J. M., Bessette, L. G., York, C., Wong, V., & Lin, K. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0063 · Cited by 10
Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis
Huang, Y., Teng, T., Giovane, C. D., Wang, R., John Suckling, A., Shen, X., Chen, S.-D., Huang, S., Kuo, K., Cai, W., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afad091 · Cited by 10
Prescribing in care homes: the role of the geriatrician
Burns, E., & McQuillan, N. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311421438 · Cited by 10
Cations, M., Lang, C. E., Ward, S. A., Caughey, G. E., Crotty, M., Whitehead, C., Ahern, S., Maddison, J., & Inacio, M. C. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89646-x · Cited by 10
A psychiatric intensive care unit for older adults: an interval comparison of admissions
Stevenson, G. S., Khan, M. A., & Perumal, N. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008503 · Cited by 10
Atypical antipsychotics as add-on treatment in late-life depression
Çakır, S., & Şenkal, Z. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s114244 · Cited by 10
Antipsychotic Drug Dispensing in Older Adults With Parkinsonism
Marras, C., Austin, P. C., Bronskill, S. E., Diong, C. C., & Rochon, P. A. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.08.003 · Cited by 10
Self-citationConcerns about health care warnings and their impact on prescribing behaviour
Katz, L. Y. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080901 · Cited by 10
Risk of Mortality Among Patients Treated With Antipsychotic Medications
Wang, L., Lee, S.-Y., Yuan, S.-S., Yang, K., Yang, C.-J., Lee, T., & Shyu, Y. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000451 · Cited by 9
Kim, D. H., Lee, S. B., Park, C. M., Levin, R., Metzger, E. D., Bateman, B. T., Ely, E. W., Pandharipande, P. P., Pisani, M. A., Jones, R. N., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3021 · Cited by 9
Reisinho, P., Raposo, R., Zagalo, N., & Ribeiro, Ó. M. (2024) · International Conference on Medical and Health Informatics (ICMHI) · doi:10.1145/3673971.3674011 · Cited by 9
Clinical Pharmacology and Vascular Risk
Silvestrelli, G., Corea, F., Micheli, S., & Lanari, A. (2010) · The Open Neurology Journal · doi:10.2174/1874205x01004010064 · Cited by 9
Use of Atypical Antipsychotics in Nursing Homes and Pharmaceutical Marketing
Pimentel, C. B., Donovan, J. L., Field, T. S., Gurwitz, J. H., Harrold, L. R., Kanaan, A. O., Lemay, C. A., Mazor, K. M., Tjia, J., & Briesacher, B. A. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13180 · Cited by 9
Self-citationFoster, P. D., Camacho, X., Vigod, S. N., Yao, Z., Juurlink, D. N., Paterson, J. M., Mamdani, M., Martins, D., & Gomes, T. (2016) · CMAJ Open · doi:10.9778/cmajo.20150095 · Cited by 9
Suzuki, Y., Sakakibara, M., Shiraishi, N., Komiya, H., Akishita, M., & Kuzuya, M. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000512043 · Cited by 9
Gustafsson, M. V., Altufaili, M., & Sjölander, M. (2022) · Drugs - Real World Outcomes · doi:10.1007/s40801-022-00341-3 · Cited by 9
Ambient Activity Technologies for Managing Responsive Behaviours in Dementia
Wilkinson, A., Kanik, M., O’Neill, J., Charoenkitkarn, V., & Chignell, M. (2017) · Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care · doi:10.1177/2327857917061008 · Cited by 9
Pereira, M., Leite, C., Campos, C., & Coelho, T. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251371236 · Cited by 8
Smith, H. C., Petersen, I., Hayes, J., Jordan, K. P., Boman, M., Banerjee, S., Walters, K. R., Cooper, C., & Bazo‐Alvarez, J. C. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00261-5 · Cited by 8
Jang, S., Kang, H.-J., Kim, Y., & Jang, S. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03681-5 · Cited by 8
Pharmacologic Treatment Strategies for Delirium in Hospitalized Adults: Past, Present, and Future
Devlin, J. W. (2024) · Seminars in Neurology · doi:10.1055/s-0044-1791246 · Cited by 8
Rosenthal, M., Poling, J., Wec, A., Connolly, E., Angell, B., & Crystal, S. (2020) · Journal of Applied Gerontology · doi:10.1177/0733464820958919 · Cited by 8
Schafer, R., Karstens, A. J., Hospelhorn, E., Wolfe, J., Ziemba, A., Wise, P., Crown, R., Rook, J., & Bonakdarpour, B. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000525 · Cited by 8
Andrade, C., & Radhakrishnan, R. (2009) · PubMed Central · Cited by 8
Guidelines on antipsychotics for dementia: are we losing our minds?
Haw, C., Yorston, G. A., & Stubbs, J. H. (2009) · Psychiatric Bulletin · doi:10.1192/pb.bp.107.017947 · Cited by 8
Worden psychofarmaca in het verpleeghuis te vaak voorgeschreven?
Koopmans, R. T. C. M. (2007) · Tijdschrift voor Gerontologie en Geriatrie · doi:10.1007/bf03074861 · Cited by 8
Psychiatric symptoms of dementia: Treatable, but no silver bullet
Schwab, W., Messinger‐Rapport, B. J., & Franco, K. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.07270 · Cited by 8
Atypical Antipsychotics, Elderly Patients, and Mortality Risk
Citrome, L. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e31815401cb · Cited by 8
Hui, T. S., Wong, A., & Wijesinghe, R. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.09.215 · Cited by 8
Bain, K. T., Schwartz, E. J., & Chan-Ting, R. (2017) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2017.090 · Cited by 8
Chu, C., Li, W.-R., Huang, K.-L., Su, P.-Y., Lin, C., & Lan, T. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780016 · Cited by 8
Howard, P. D., Twycross, R., Shuster, J. L., Mihalyo, M., & Wilcock, A. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.03.002 · Cited by 8
Antipsychotic use varies by patient age.
Cascade, E. F., Kalali, A. H., & Citrome, L. (2007) · PubMed Central · Cited by 8
The use of atypical antipsychotics in dementia: rethinking Simpson's paradox
Suh, G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008485 · Cited by 8
Do Antipsychotics Cost Lives or Save Lives? Risks Versus Benefits From Large Epidemiological Studies
Mitchell, A. J. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c1b44a · Cited by 8
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease
Bennett, C. G., Guttmann, R. P., Hackney, M. E., Amin, R., & Weaver, S. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241298529 · Cited by 7
Tan, T. C., Lau, E. C. Y., Le, T. H., Lu, C. Y., Hilmer, S. N., Jeon, Y., Low, L., & Tan, E. C. K. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01202-8 · Cited by 7
Wilkinson, A., Charoenkitkarn, V., O’Neill, J., Kanik, M., & Chignell, M. (2017) · International World Wide Web Conference (WWW) · doi:10.1145/3041021.3054933 · Cited by 7
Rangfast, I., Sönnerstam, E., & Gustafsson, M. V. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03240-y · Cited by 7
Kanzaki, T., Uju, Y., Sekine, K., Ishii, Y., Yoshimi, T., Yasui, R., Yasukawa, A., Sato, M., Okamoto, S., Hisaoka, T., et al. (2015) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.14m01713 · Cited by 7
Wada, S., Sadahiro, R., Matsuoka, Y., Uchitomi, Y., Yamaguchi, T., & Shimizu, K. (2019) · Trials · doi:10.1186/s13063-019-3202-1 · Cited by 7
Zhu, L., Rochon, P. A., Gruneir, A., Wu, W., Giannakeas, V., Austin, P. C., Stall, N. M., McCarthy, L. M., Alberga, A., Herrmann, N., et al. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00690-9 · Cited by 7
Self-citationTo Prescribe or Not to Prescribe? Atypical Antipsychotic Drugs in Patients with Dementia
Jeste, D. V., & Meeks, T. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e3181514c51 · Cited by 7
Sinvani, L., Strunk, A., Ardito, S., Gordon, S., Liu, Y., Schantz, E., Arroon, A., Ilyas, A., Gromova, V., Polokowski, A. R., et al. (2023) · Gerontology and Geriatric Medicine · doi:10.1177/23337214231192162 · Cited by 6
Bohlken, J., Booker, A., & Kostev, K. (2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-104931 · Cited by 6
Colling, C., Mueller, C., Perera, G., Funnell, N., Sauer, J., Harwood, D., Stewart, R. J., & Bishara, D. (2020) · BMJ Open Quality · doi:10.1136/bmjoq-2019-000778 · Cited by 6
García‐Alberca, J. M., de la Rosa, M. D., de Zaldívar, P. S., Ledesma, M., Oltra, E., Gris, E., Ocejo, O., Torrecilla, J., Zafra, C., Sánchez-Fernández, A., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230391 · Cited by 6
Prescribing Optimal Drug Therapy for Older People: Sending the Right Message
Rochon, P. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.473 · Cited by 6
Self-citationSleep in Independently Living and Institutionalized Elderly
Bliwise, D. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00136-5 · Cited by 6
Maeda, Y., Fukushima, K., Kyoutani, S., Butler, J. P., Fujii, M., & Sasaki, H. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.252.263 · Cited by 6
Antipsychotics in Alzheimer's disease: A critical analysis
da Silva, E. M., Braga, R. D. C. O. P., Avelino‐Silva, T. J., & Gil, L. A. (2011) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642011dn05010007 · Cited by 6
Nursing and music: Considerations of Nightingale’s environmental philosophy and phenomenology
Vijinski, J. P., Hirst, S. P., & Goopy, S. E. (2018) · Nursing Philosophy · doi:10.1111/nup.12223 · Cited by 6
Antipsychotic drug use and favourable natures of emotional functions in patients with dementia
Fujii, M., Butler, J. P., & Sasaki, H. (2019) · Psychogeriatrics · doi:10.1111/psyg.12404 · Cited by 6
Martínez, L. M., Fernández, M. R. O., & Corrales, G. P. (2009) · Farmacia Hospitalaria · doi:10.1016/s1130-6343(09)72168-3 · Cited by 6
Watt, J. A., Ismail, Z., Lane, N. E., Seitz, D. P., & Goodarzi, Z. (2026) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-061724-085912 · Cited by 5
Association of Antipsychotic Dose With Survival of Advanced Cancer Patients With Delirium
Yokomichi, N., Maeda, I., Morita, T., Yoshiuchi, K., Ogawa, A., Hisanaga, T., Sakashita, A., Nakahara, R., Kaneishi, K., & Iwase, S. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.03.005 · Cited by 5
Solhaug, V., Waade, R. B., Molden, E., Størset, E., Høiseth, G., & Tveito, M. (2025) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001309 · Cited by 5
Metadata
- Authors
- Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., Gurwitz, J. H., & Rochon, P. A.
- Affiliations
- Harvard University (US)
- From Queen's University, Kingston, Ontario, Canada; Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada; Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; University of British Columbia, Vancouver, British Columbia, Canada; and Meyers Primary Care Institute of the University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts.
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-06-05
- Volume
- 146
- Issue
- 11
- Pages
- 775-786
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2144855317
- Cited by
- 624
- References
- 66
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 22 · 2022: 30 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 38 · 2017: 36 · 2016: 45 · 2015: 42 · 2014: 30 · 2013: 37 · 2012: 35
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- antipsychotic drugs, atypical antipsychotics, typical antipsychotics, dementia, all-cause mortality, older adults, behavioral and psychological symptoms of dementia, long-term care, community-dwelling older adults, drug safety
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Humans, Male, Ontario, Sensitivity and Specificity, Time Factors, Antipsychotic Agents, Matched-Pair Analysis, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
